Showing results (1311-1320 of 8,142) with videos related to

Sort By:
Pageof 815
Haematologica|October 23, 2025
Children with chronic phase chronic myeloid leukemia: characteristics and outcomes from the International Registry of Childhood CMLFrédéric Millot, Joe De Keizer, Markus Metzler, et al.
Haematologica|July 24, 2025
Proteomic shifts post plasma cell therapy in AL amyloid plaques and potential implications for light chain directed anti-fibril monoclonal antibodiesMatthew J Rees, Surendra Dasari, Ellen D McPhail, et al.
Haematologica|July 24, 2025
Don't lose sight: rare extramedullary involvement of myeloid/lymphoid neoplasm with ETV6:ABL1 translocation in blast phaseNeta Sternbach, Omer Y Bialer, Alon Rozental, et al.
Haematologica|July 24, 2025
Longer time from diagnosis to initiation of hypomethylating agents plus venetoclax for acute myeloid leukemia does not worsen survival: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)Samuel J Yates, Julian J Weiss, Abigail Sneider, et al.
Haematologica|July 24, 2025
Altered platelet lipidome in bleeding patients with unexplained platelet function defectsBianca De Jonckheere, Dino Mehic, Dominik Kopczynski, et al.
Haematologica|July 1, 1989
Bone marrow morphology and proliferative activity in acquired immunodeficiency syndromeM Danova, A Riccardi, S Brugnatelli, et al.
Haematologica|July 1, 1989
Neonatal thrombocytopenic purpura: case reports and methodological approachP Borzini, C Radaelli, G Assali, et al.
Haematologica|August 3, 2014
Reduced-toxicity conditioning prior to allogeneic stem cell transplantation improves outcome in patients with myeloid malignanciesClaire Oudin, Patrice Chevallier, Sabine Furst, et al.
Haematologica|August 3, 2014
Impact of the International Prognostic Scoring System cytogenetic risk groups on the outcome of patients with primary myelodysplastic syndromes undergoing allogeneic stem cell transplantation from human leukocyte antigen-identical siblings: a retrospective analysis of the European Society for Blood and Marrow Transplantation-Chronic Malignancies Working PartyFrancesco Onida, Ronald Brand, Anja van Biezen, et al.
Haematologica|December 3, 2013
Loss of ATE1-mediated arginylation leads to impaired platelet myosin phosphorylation, clot retraction, and in vivo thrombosis formationLurong Lian, Aae Suzuki, Vincent Hayes, et al.
Pageof 815